Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Lung Cancer

Volumn 77, Issue 1, 2012, Pages 89-96

  Wang, Luhua ^a   Wu, Shixiu ^b   Ou, Guangfei ^a   Bi, Nan ^a   Li, Wenfeng ^b   Ren, Hua ^a   Cao, Jianzhong ^a   Liang, Jun ^a   Li, Junling ^a   Zhou, Zongmei ^a   Lv, Jima ^a   Zhang, Xiangru ^a  

^a CANCER HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Carboplatin; Cisplatin; Concurrent chemoradiation; Etoposide; Locally advanced; NSCLC; Paclitaxel

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DRUG SAFETY; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGITIS; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUTROPENIA; PACLITAXEL; RADIATION PNEUMONITIS; TREATMENT OUTCOME;

EID: 84862802175     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.02.011     Document Type: Article

References (26)

1. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S., et al. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004, 22:330-353.
2. Curran W.J., Paulus R., Langer C.J., Komaki R., Lee J.S., Hauser S., et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011, 103:1452-1460.
3. Baggstrom M.Q., Stinchcombe T.E., Fried D.B., Poole C., Hensing T.A., Socinski M.A. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis. J Thorac Oncol 2007, 2:845-853.
4. Albain K.S., Crowley J.J., Turrisi A.T., Gandara D.R., Farrar W.B., Clark J.I., et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic sage IIIB no-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 2001, 20:3454-3460.
5. Lee J.S., Scott C., Komaki R., Fossella F.V., Dundas G.S., McDonald S., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996, 14:1055-1064.
6. Gandara D.R., Chansky K., Albain K.S., Leigh B.R., Gaspar L.E., Lara P.N., et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 2002, 21:2004-2010.
7. Park J., Ahn Y.C., Kim H., Lee S.H., Park S.H., Lee K.E., et al. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers. Lung Cancer 2003, 42:227-235.
8. Mostafa E., Khatab A., Al-Adwy E.R., Al-Assal G.M. Limited field radiotherapy concomitant with cisplatin/etoposide followed by consolidation docetaxel for the treatment of inoperable stage III non-small cell lung cancer. J Egypt Nat Cancer Inst 2007, 19:28-38.
9. Movsas B., Langer C.J., Ross H.J., Wang L., Jotte R.M., Feigenberg S., et al. Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer. J Thorac Oncol 2010, 5(5):673-679.
10. Fournel P., Robinet G., Thomas P., Souquet P.J., Léna H., Vergnenégre A., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienned'Oncologie Thoracique-Groupe Francais de Pneumo-Cancérologie NPC 95-01 Study. J Clin Oncol 2005, 23:5910-5917.
11. Hanna N., Neubauer M., Yiannoutsos C., McGarry R., Arseneau J., Ansari R., et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 2008, 26:5755-5760.
12. Schild S.E., Stella P.J., Geyer S.M., Bonner J.A., Marks R.S., McGinnis W.L., et al. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 54:370-378.
13. Kelly K., Chansky K., Gaspar L.E., Albain K.S., Jett J., Ung Y.C., et al. Phase III Trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol 2008, 26:2450-2456.
14. Albain K.S., Swann R.S., Rusch V.W., Turrisi A.T., Shepherd F.A., Smith C., et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009, 374:379-386.
15. Pallares C., Capdevila J., Paredee A., Farré N., Ciria J.P., Membrive I., et al. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial. Lung Cancer 2007, 58(2):238-245.
16. Akerley W., Herndon J.E., Lyss A.P., Choy H., Turrisi A., Graziano S., et al. Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study-CALGB 9534. Clin Lung Cancer 2005, 7:47-53.
17. Wang J., Pang Q.S., Wang P., Wang J., Wang W. Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer. Zhonghua Zhong Liu Za Zhi 2007, 29:769-772. [article in Chinese].
18. Stinchcombe T.E., Morris D.E., Lee C.B., Moore D.T., Hayes D.N., Halle J.S., et al. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer. J Thorac Oncol 2008, 3:250-257.
19. Belani C.P., Choy H., Bonomi P., Scott C., Travis P., Haluschak J., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 2005, 23:5883-5891.
20. Lau D., Leigh B., Gandara D., Edelman M., Morgan R., Israel V., et al. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. J Clin Oncol 2001, 19:442-447.
21. Huber R.M., Flentje M., Schmidt M., Pöllinger B., Gosse H., Willner J., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 2006, 24:4397-4404.
22. Vokes E.E., Herndon J.E., Kelley M.J., Cicchetti M.G., Ramnath N., Neill H., et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and leukemia group B. J Clin Oncol 2007, 25:1698-1704.
23. Movsas B., Scott C., Langer C., Werner-Wasik M., Nicolaou N., Komaki R., et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group Trial 98-01. J Clin Oncol 2005, 23:2145-2154.
24. Yamamoto N., Nakagawa K., Nishimura Y., Tsujino K., Satouchi M., Kudo S., et al. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. J Clin Oncol 2010, 28(23):3739-3745.
25. Choy H., Safran H., Akerlley W., Graziano S., Bogart J., Cole B. Phase II trial of weekly paclitaxol and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin Cancer Res 1998, 4:1931-1936.
26. Havemann K., Wolf M., Görg C., Hackenbruch E., Pfab R., Görg K. Preclinical and clinical experience with cisplatin and carboplatin and simultaneous radiation in non-small cell lung cancer. Ann Oncol 1992, (Suppl. 3):33-37.